Vaccination in adult patients with chronic inflammatory rheumatic diseases;Impfung bei erwachsenen Patienten mit chronisch entzündlichen rheumatischen Erkrankungen

Zeitschrift fur Rheumatologie

Volumn 72, Issue 7, 2013, Pages 690-704

  Goldacker, S ^a   Gause, A M ^b   Warnatz, K ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Schwerpunktpraxis für Rheumatologie und Autoimmunerkrankungen   (Germany)

Author keywords

Immunosuppression; Infection; Infection susceptibility; Pneumococcus; Standard vaccinations

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; INFLUENZA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE;

ARTICLE; HAEMOPHILUS INFECTION; HUMAN; INFECTION PREVENTION; INFLUENZA; MENINGOCOCCEMIA; PNEUMOCOCCAL INFECTION; RHEUMATIC DISEASE;

GERMANY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PRACTICE GUIDELINES AS TOPIC; RHEUMATIC DISEASES; RHEUMATOLOGY; VACCINATION;

EID: 84883657659     PISSN: 03401855     EISSN: 14351250     Source Type: Journal    
DOI: 10.1007/s00393-013-1155-4     Document Type: Article

References (80)

1. Luis A de, Pigrau C, Pahissa A et al (1990) Infections in 96 cases of systemic lupus erythematosus. Med Clin (Barc) 94(16):607-610
2. Massardo L, Martinez ME, Baro M et al (1991) Infections in systemic lupus erythematosus. Rev Med Chil 119(10):1115-1122
3. Oh HM, Chng HH, Boey ML, Feng PH (1993) Infections in systemic lupus erythematosus. Singapore Med J 34(5):406-408
4. Shyam C, Malaviya AN (1996) Infection-related morbidity in systemic lupus erythematosus: a clinico-epidemiological study from northern India. Rheumatol Int 16(1):1-3
5. Paton NI (1997) Infections in systemic lupus erythematosus patients. Ann Acad Med Singapore 26(5):694-700
6. Feuchtenberger M, Kleinert S, Schwab S et al (2011) Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study. Rheumatol Int 32(6):1533-1539
7. Fahy WA, Farnworth E, Yeldrem KP et al (2006) Pneumococcal and influenza vaccination in patients with rheumatic conditions and receiving DMARD therapy. Rheumatology (Oxford) 45(7):912-913
8. Pradeep J, Watts R, Clunie G (2007) Audit on the uptake of influenza and pneumococcal vaccination in patients with rheumatoid arthritis. Ann Rheum Dis 66(6):837-838
9. Koutsogeorgopoulou L, Antoniadis C, Vassilopoulos D, Kassimos D (2009) Preventive influenza vaccination for patients with rheumatoid arthritis. A need for an international campaign. Clin Rheumatol 28(1):103-104
10. Stojanovich L (2006) Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Clin Dev Immunol 13(2-4):373-375
11. Duchet-Niedziolka P, Launay O, Coutsinos Z et al (2009) Vaccination in adults with auto-immune disease and/or drug related immune deficiency: results of the GEVACCIM Delphi survey. Vaccine 27(10):1523-1529
12. Heijstek MW, Pileggi GC, Zonneveld-Huijssoon E et al (2007) Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis. Ann Rheum Dis 66(10):1384-1387
13. Borte S, Liebert UG, Borte M, Sack U (2009) Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept. Rheumatology (Oxford) 48(2):144-148
14. Mota LM, Oliveira AC, Lima RA et al (2009) Vaccination against yellow fever among patients on immunosuppressors with diagnoses of rheumatic diseases. Rev Soc Bras Med Trop 42(1):23-27
15. Harpaz R, Ortega-Sanchez IR, Seward JF (2008) Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 57(RR-5):1-30
16. Elkayam O, Amir S, Mendelson E et al (2011) Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases. Arthritis Care Res (Hoboken) 63, 1062-1067
17. Evison J, Farese S, Seitz M et al (2009) Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients. Clin Infect Dis 48(10):1402-1412
18. Holvast A, Huckriede A, Wilschut J et al (2006) Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis 65(7):913-918
19. Moberley SA, Holden J, Tatham DP, Andrews RM (2008) Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev (1):CD000422
20. Centers for Disease Control CDC (2008) Progress in introduction of pneumococcal conjugate vaccine-worldwide, 2000-2008. MMWR Morb Mortal Wkly Rep 57(42):1148-1151
21. Metlay JP, Fishman NO, Joffe M, Edelstein PH (2006) Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults. Vaccine 24(4):468-475
22. Carvalho JF de, Pereira RM, Shoenfeld Y (2008) Systemic polyarteritis nodosa following hepatitis B vaccination. Eur J Intern Med 19(8):575-578
23. Carmeli Y, Oren R (1993) Hepatitis B vaccine side-effect. Lancet 341(8839):250-251
24. Elkayam O, Yaron M, Caspi D (2002) Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis. Ann Rheum Dis 61(7):623-625
25. Mast EE, Weinbaum CM, Fiore AE et al (2006) A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 55(RR-16):1-33
26. Dengler TJ, Zimmermann R, Meyer J et al (1999) Vaccination against tick-borne encephalitis under therapeutic immunosuppression. Reduced efficacy in heart transplant recipients. Vaccine 17(7-8):867-874
27. Nath R, Mant C, Luxton J et al (2007) High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients. Arthritis Rheum 57(4):619-625
28. Mok CC, Ho LY, Fong LS, To CH (2012) Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study. Ann Rheum Dis [Epub ahead of print]
29. Wiese-Posselt M, Hellenbrand W (2010) Changes to the varicella and pertussis immunisation schedule in Germany 2009: background, rationale and implementation. Euro Surveill 15(16)pii:19548
30. Geier DA, King PG, Sykes LK, Geier MR (2008) RotaTeq vaccine adverse events and policy considerations. Med Sci Monit 14(3):H9-H16
31. Roux A de, Schmole-Thoma B, Siber GR et al (2008) Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis 46(7):1015-1023
32. Roux A de, Marx A, Burkhardt O et al (2006) Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients. Vaccine 24(10):1537-1542
33. Kapetanovic MC, Saxne T, Sjoholm A et al (2006) Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford) 45(1):106-111
34. Fomin I, Caspi D, Levy V et al (2006) Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis 65(2):191-194
35. Mazzone PJ, Mossad SB, Mawhorter SD et al (2001) The humoral immune response to influenza vaccination in lung transplant patients. Eur Respir J 18(6):971-976
36. Versluis DJ, Beyer WE, Masurel N et al (1986) Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation 42(4):376-379
37. Dengler TJ, Strnad N, Buhring I et al (1998) Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. Transplantation 66(10):1340-1347
38. Abu-Shakra M, Press J, Varsano N et al (2002) Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol 29(12):2555-2557
39. Battafarano DF, Battafarano NJ, Larsen L et al (1998) Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum 41(10):1828-1834
40. Salles MJ, Sens YA, Boas LS, Machado CM (2010) Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs. Clin Transplant 24(1): E17-E23
41. Lipnick RN, Karsh J, Stahl NI et al (1985) Pneumococcal immunization in patients with systemic lupus erythematosus treated with immunosuppressives. J Rheumatol 12(6):1118-1121
42. Kaine JL, Kivitz AJ, Birbara C, Luo AY (2007) Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J Rheumatol 34(2):272-279
43. Mease PJ, Ritchlin CT, Martin RW et al (2004) Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. J Rheumatol 31, 1356-1361
44. Del PF, Lagana B, Biselli R et al (2006) Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity. Vaccine 24(16):3217-3223
45. Keshtkar-Jahromi M, Argani H, Rahnavardi M et al (2008) Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: a controlled trial. Am J Nephrol 28(4):654-660
46. Rentenaar RJ, Diepen FN van, Meijer RT et al (2002) Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo. Kidney Int 62(1):319-328
47. Kapetanovic MC, Saxne T, Nilsson JA, Geborek P (2007) Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology (Oxford) 46(4):608-611
48. Visvanathan S, Keenan GF, Baker DG et al (2007) Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone. J Rheumatol 34(5):952-957
49. Gelinck LB, Bijl AE van der, Beyer WE et al (2008) The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis 67(5):713-716
50. Elkayam O, Bashkin A, Mandelboim M et al (2009) The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 39(6):442-447
51. Gelinck LB, Teng YK, Rimmelzwaan GF et al (2007) Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab. Ann Rheum Dis 66(10):1402-1403
52. Albert D, Dunham J, Khan S et al (2008) Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus. Ann Rheum Dis 67(12):1724-1731
53. Horwitz SM, Negrin RS, Blume KG et al (2004) Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. Blood 103(3):777-783
54. Bearden CM, Agarwal A, Book BK et al (2005) Rituximab inhibits the in vivo primary and secondary antibody response to a neoantigen, bacteriophage phiX174. Am J Transplant 5(1):50-57
55. Kolk LE van der, Baars JW, Prins MH, Oers MH van (2002) Rituximab treatment results in impaired secondary humoral immune responsiveness. Blood 100(6):2257-2259
56. Bingham CO III, Looney RJ, Deodhar A et al (2010) Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial. Arthritis Rheum 62(1):64-74.
57. van Assen S, Holvast A, Benne CA et al (2010) Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis Rheum 62(1):75-81
58. Edwards JC, Szczepanski L, Szechinski J et al (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350(25):2572-2581
59. Cambridge G, Leandro MJ, Teodorescu M et al (2006) B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles. Arthritis Rheum 54(11):3612-3622
60. Vallerskog T, Gunnarsson I, Widhe M et al (2007) Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Clin Immunol 122(1):62-74
61. Tay L, Leon F, Vratsanos G et al (2007) Vaccination response to tetanus toxoid and 23-valent pneumococcal vaccines following administration of a single dose of abatacept: a randomized, open-label, parallel group study in healthy subjects. Arthritis Res Ther 9(2):R38
62. Mori S, Ueki Y, Akeda Y et al (2013) Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy. Ann Rheum Dis 72(8):1362-1366
63. Mori S, Ueki Y, Hirakata N et al (2012) Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis. Ann Rheum Dis 71(12):2006-2010
64. Elkayam O, Caspi D, Reitblatt T et al (2004) The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 33 283-288.
65. Williams GW, Steinberg AD, Reinertsen JL et al (1978) Influenza immunization in systemic lupus eruthematosus. A double-blind trial. Ann Intern Med 88(6):729-734
66. Brodman R, Gilfillan R, Glass D, Schur PH (1978) Influenzal vaccine response in systemic lupus erythematosus. Ann Intern Med 88(6):735-740
67. Louie JS, Nies KM, Shoji KT et al (1978) Clinical and antibody responses after influenza immunization in systemic lupus erythematosus. Ann Intern Med 88(6):790-792
68. Ristow SC, Douglas RG Jr, Condemi JJ (1978) Influenza vaccination of patients with systemic lupus erythematosus. Ann Intern Med 88(6):786-789
69. Herron A, Dettleff G, Hixon B et al (1979) Influenza vaccination in patients with rheumatic diseases. Safety and efficacy. JAMA 242(1):53-56
70. Klippel JH, Karsh J, Stahl NI et al (1979) A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus. Arthritis Rheum 22. 1321-1325.
71. Elkayam O, Paran D, Burke M et al (2005) Pneumococcal vaccination of patients with systemic lupus erythematosus: effects on generation of autoantibodies. Autoimmunity 38(7):493-496
72. Kuruma KA, Borba EF, Lopes MH et al (2007) Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus. Lupus 16(5):350-354
73. Setti M, Fenoglio D, Ansaldi F et al (2009) Flu vaccination with a virosomal vaccine does not affect clinical course and immunological parameters in scleroderma patients. Vaccine 27(25-26):3367-3372
74. Mader R, Narendran A, Lewtas J et al (1993) Systemic vasculitis following influenza vaccination-report of 3 cases and literature review. J Rheumatol 20(8):1429-1431
75. Schattner A (2005) Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 23(30):3876-3886
76. Holvast A, Stegeman CA, Benne CA et al (2009) Wegener's granulomatosis patients show an adequate antibody response to influenza vaccination. Ann Rheum Dis 68(6):873-878
77. Stassen PM, Sanders JS, Kallenberg CG, Stegeman CA (2008) Influenza vaccination does not result in an increase in relapses in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 23(2):654-658
78. Sahin N, Salli A, Enginar AU, Ugurlu H (2009) Reactive arthritis following tetanus vaccination: a case report. Mod Rheumatol 19(2):209-211
79. Gross K, Combe C, Kruger K, Schattenkirchner M (1995) Arthritis after hepatitis B vaccination. Report of three cases. Scand J Rheumatol 24(1):50-52
80. Assen S van, Agmon-Levin N, Elkayam O et al (2011) EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 70, 414-422